title: Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.
abstract: Testicular cancer is the most common cancer in men aged 15 to 40 years in the United States, Canada, and many European countries. Given the excellent prognosis of most men with testicular cancer, updates in care after treatment have become very important. This article provides a review of the available evidence, integrated with expert medical judgment, in the area of testicular cancer follow-up.
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Clair J
authors.initials: CJ
authors.lastname: Beard
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Shilpa
authors.initials: S
authors.lastname: Gupta
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Motzer
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Elizabeth K
authors.initials: EK
authors.lastname: O'Donnell
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Plimack
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Kim A
authors.initials: KA
authors.lastname: Margolin
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Ryan
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Joel
authors.initials: J
authors.lastname: Sheinfeld
authors.affiliation: From Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Division of Medical Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Division of Oncology, Stanford University Medical Center, Palo Alto, California; Division of Hematology/Oncology, The University of California, San Francisco, California; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Darren R
authors.initials: DR
authors.lastname: Feldman
mesh_terms: D003131:Combined Modality Therapy; D032921:Consensus; D019468:Disease Management; D005500:Follow-Up Studies; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D013736:Testicular Neoplasms / Q000628:therapy*; D016896:Treatment Outcome